Infinium Global Diversity Array Kits.

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition to Illumina, Inc. for the procurement of Infinium Global Diversity Array Kits. The NIH is taking this approach because Illumina, Inc. is uniquely situated to provide technical support for the arrays and reagents in the case of assay failure. The company's product support service team includes highly qualified technical applications scientists and field application scientists who are deeply familiar with the intricacies of the assay system and are able to troubleshoot and provide replacement reagents if necessary. • The contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. • The acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). • Interested parties may identify their interest and capability to respond to this notice, and responses must be received by July 2nd, 2026, at 9:00 AM Eastern time.